A drug in the clinical testing stage could potentially extend people's lives by a quarter

There are dozens of legends discussing the fountain of youth, thanks to the human obsession with finding immortality. Staying youthful and living longer is a very common interest among the human race. If there was a drug that could stop the aging process and extend your life, would you take it? This question may no longer be hypothetical for long. Testing on a brand new drug has proved successful in extending the life of its animal hosts without negative side effects. In the very near future, they'll be testing the drug on humans. It all started when a drug company named Novartis gave low doses of the everolimus drug to a randomly selected group of 65-plus aged participants. The goal was to see if the drug could make flu vaccines more effective. As a direct result of the drug administration, efficacy rose by 20 percent.

$15 provides access to this article and every case-study, interview, and analysis piece that we publish for the next 30 days. Our Premium Subscription also provides access to a database of over 100,000 articles on innovation in brand, customer, and retail experience.
Already a subscriber? Log in.